Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML) ; volume:8 ; number:1 ; day:13 ; month:2 ; year:2008 ; pages:1-9 ; date:12.2008
BMC cancer ; 8, Heft 1 (13.2.2008), 1-9, 12.2008
- Urheber
-
Tang, Ruoping
- Beteiligte Personen und Organisationen
-
Faussat, Anne-Marie
Perrot, Jean-Yves
Marjanovic, Zora
Cohen, Simy
Storme, Thomas
Morjani, Hamid
Legrand, Ollivier
Marie, Jean-Pierre
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-51
- URN
-
urn:nbn:de:1111-2016030347944
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Ruoping
- Faussat, Anne-Marie
- Perrot, Jean-Yves
- Marjanovic, Zora
- Cohen, Simy
- Storme, Thomas
- Morjani, Hamid
- Legrand, Ollivier
- Marie, Jean-Pierre
- SpringerLink (Online service)
Ähnliche Objekte (12)
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma through P-glycoprotein
P-glycoprotein transporter in drug development
siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
Inhibition of P-glycoprotein by two artemisinin derivatives
Cytotoxicity and P-glycoprotein inhibition by cardiotonic steroids
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
Regulation of P-glycoprotein at the blood-brain barrier
Regulation of P-glycoprotein at the blood-brain barrier
Decreased blood-brain barrier P-glycoprotein function with aging
Funktionelle Komplementierung des cystic fibrosis transmembrane conductance regulator (CFTR) durch Überexpression des membranständigen Transportproteins P-Glycoprotein : Untersuchung des ATP-Transportes durch P-Glycoprotein
Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein